249 related articles for article (PubMed ID: 6427840)
1. [Identification and sensitivity of Streptococci to antibiotics].
Monaci E
Quad Sclavo Diagn; 1983 Jun; 19(2):223-9. PubMed ID: 6427840
[TBL] [Abstract][Full Text] [Related]
2. [Antibiotics susceptibility of Streptococcus and Enterococcus: data of Onerba network].
Vachée A; Varon E; Jouy E; Meunier D;
Pathol Biol (Paris); 2009 May; 57(3):240-4. PubMed ID: 18343047
[TBL] [Abstract][Full Text] [Related]
3. [The implications of non-group-A streptococci in human pathology].
Ungureanu V; Gheorghe M; Ghiţă M; Ciucă I; Georgescu R; Florescu DP
Bacteriol Virusol Parazitol Epidemiol; 1998; 43(4):221-7. PubMed ID: 10422316
[No Abstract] [Full Text] [Related]
4. Activity of iclaprim against clinical isolates of Streptococcus pyogenes and Streptococcus agalactiae.
Morrissey I; Maher K; Hawser S
J Antimicrob Chemother; 2009 Feb; 63(2):413-4. PubMed ID: 19059943
[No Abstract] [Full Text] [Related]
5. [Sensitivity of bacteria isolated from non-parenteral drugs to antibiotics. II. Sensitivity of gram-positive strains].
Zembrzuska E
Acta Pol Pharm; 1981; 38(1):123-8. PubMed ID: 6797259
[No Abstract] [Full Text] [Related]
6. Streptococcal update. A microbiology perspective.
Asche V
Aust Fam Physician; 1993 Oct; 22(10):1763-8. PubMed ID: 8280000
[TBL] [Abstract][Full Text] [Related]
7. The combined actions of saliva, human amylase and antibiotics on Streptococcus pyogenes and Streptococcus agalactiae.
Rotimi VO; Eke PI
East Afr Med J; 1985 Apr; 62(4):236-42. PubMed ID: 2412781
[No Abstract] [Full Text] [Related]
8. [Occurrence and drug-resistance of beta-hemolytic streptococci].
Mikołajczyk D; Budzyńska A; Kaczmarek A; Gospodarek E
Med Dosw Mikrobiol; 2007; 59(4):301-7. PubMed ID: 18416122
[TBL] [Abstract][Full Text] [Related]
9. [Rapid methods useful for determination of streptococcal groups with special reference to streptococci of groups B and D].
Rusu V; Dorobăţ O
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1979; 24(2):115-22. PubMed ID: 111335
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of novel rifamycins against gram-positive clinical isolates.
Murphy CK; Karginova E; Sahm D; Rothstein DM
J Antibiot (Tokyo); 2007 Sep; 60(9):572-6. PubMed ID: 17917240
[TBL] [Abstract][Full Text] [Related]
11. Can interchangeability of lincosamides be assumed in clinical practice? Comparative MICs of clindamycin and lincomycin for Streptococcus pyogenes, Streptococcus agalactiae and Staphylococcus aureus.
Porter MC; Henderson BA; Healy PE; Coombs GW; Ingram PR; McLellan D; Clark B
J Antimicrob Chemother; 2014 Mar; 69(3):856-7. PubMed ID: 24164721
[No Abstract] [Full Text] [Related]
12. Incidence, clinical distribution, and susceptibility to several antibiotics of enterococci isolated in some Italian regions.
Stefani S; Fontana R; Gesu G; Maida A; Nicoletti G; Pechmann A; Pompei R; Prenna M; Rossi L; Soro O
Chemioterapia; 1987 Jun; 6(2 Suppl):22-3. PubMed ID: 3151343
[No Abstract] [Full Text] [Related]
13. Antibiotic resistant beta-hemolytic streptococci.
Lloyd CA; Jacob SE; Menon T
Indian J Pediatr; 2007 Dec; 74(12):1077-80. PubMed ID: 18174640
[TBL] [Abstract][Full Text] [Related]
14. Should bacitracin sensitivity be used in the presumptive identification of group A streptococci?
Menon T; Lloyd C; Jacob S
Indian J Med Microbiol; 2005 Oct; 23(4):275. PubMed ID: 16327133
[No Abstract] [Full Text] [Related]
15. [Update on the susceptibility of streptococci to antibiotics (enterococci and Streptococcus pneumoniae excluded)].
Faibis F; Fiacre A; Demachy MC
Ann Biol Clin (Paris); 2003; 61(1):49-59. PubMed ID: 12604386
[TBL] [Abstract][Full Text] [Related]
16. The recent aspects of group D Streptococcus sensitivity to antibiotics.
Turcu T; Mihalcu F; Cuciureanu G; Negurţ E; Stănescu C
Arch Roum Pathol Exp Microbiol; 1981; 40(3):199-204. PubMed ID: 6800340
[No Abstract] [Full Text] [Related]
17. The effects of chemotherapeutics on the species streptococcus in vitro.
Výmola F; Jedlicková Z
J Hyg Epidemiol Microbiol Immunol; 1975; 19(3):383-8. PubMed ID: 1102599
[TBL] [Abstract][Full Text] [Related]
18. Determination of Tedizolid susceptibility interpretive criteria for gram-positive pathogens according to clinical and laboratory standards institute guidelines.
Bensaci M; Flanagan S; Sandison T
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):214-220. PubMed ID: 29277464
[TBL] [Abstract][Full Text] [Related]
19. [Sensitivity of groups A, B and C beta hemolytic streptococci to antibiotics].
González-Lama Z; González JJ; Tejedor MT; Lupiola P
Rev Esp Quimioter; 1999 Sep; 12(3):215-9. PubMed ID: 10878511
[TBL] [Abstract][Full Text] [Related]
20. [Transfer of plasmid-determined antibiotic resistance in group A, B, C and G streptococci].
Zakharieva S; Valerianov Ts
Acta Microbiol Bulg; 1980; 6():17-24. PubMed ID: 7041525
[No Abstract] [Full Text] [Related]
[Next] [New Search]
